Market Overview

Sanofi Q2 Net Profit Surges 16%

Share:
Related SNY
Benzinga's M&A Chatter for Wednesday May 25, 2016
Medivation Advises Its Shareholders To Spurn Sanofi's Move To Replace Entire Board
Ad Comm backs approval of Sanofi's diabetes combo drug iGlarLixi (Seeking Alpha)

Sanofi SA (NYSE: SNY) posted a rise in its second-quarter net profit.

Sanofi's net profit attributable to shareholders climbed 16% to 1.17 billion euros (US$1.4 billion), versus EUR1.01 billion, in the year-ago period. Its business net income fell 9.6% to EUR1.94 billion.

Analysts were expecting a business net profit of EUR1.88 billion. Its net sales gained 6.2% to EUR8.87 billion.

Sanofi shares closed at $37.85 yesterday.

Posted-In: profitEarnings News

 

Related Articles (SNY)

View Comments and Join the Discussion!